Cadrenal Therapeutics, Inc. (CVKD) vs Mustang Bio, Inc. (MBIO)
Cadrenal Therapeutics, Inc. and Mustang Bio, Inc. are both Biotechnology companies. Cadrenal Therapeutics, Inc. and Mustang Bio, Inc. are of similar size ($4.3M and $4.0M). Across the 9 metrics below, Mustang Bio, Inc. leads on 7 and Cadrenal Therapeutics, Inc. on 2.
Valuation
Profitability
| Metric | CVKD | MBIO | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (275.16%) | (58.12%) | (57.72%) |
| Return on assets | (199.59%) | (21.17%) | (49.22%) |
| Return on invested capital | (427.54%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack